Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Strategic Expansion into AI-Powered Healthcare Solutions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Khiron Life Sciences Corp V.KHRN.H

Alternate Symbol(s):  V.KHRN.W.H | KHRNF | KHRWF

Healthcare Cannabis
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

Recent & Breaking News (TSXV:KHRN.H)

Khiron Life Sciences to Present at Upcoming November Investor Conferences

PR Newswire November 8, 2021

Khiron Opens First clinic in Europe with Zerenia(TM) Clinics UK

PR Newswire November 3, 2021

Khiron Life Sciences Corp.: Invitation to the Benzinga Cannabis Capital Conference

Newsfile October 7, 2021

Khiron presents its first research study with 1,400 patients

PR Newswire October 7, 2021

Khiron Life Sciences to Present at Upcoming October Investor Conferences

PR Newswire October 4, 2021

Khiron reports medical cannabis prescription growth in South America and Europe

PR Newswire October 4, 2021

Khiron's Announces Resignation of Chief Financial Officer Swapan Kakumanu of RTB LLP appointed as Interim CFO

PR Newswire October 1, 2021

Khiron Receives Approval To Renew Its Normal Course Issuer Bid

PR Newswire September 13, 2021

Khiron Announces Intention to Renew its Normal Course Issuer Bid

PR Newswire September 9, 2021

Khiron Registers its First Two Medical Cannabis Products in Peru, Available for Sale Nationwide

PR Newswire August 31, 2021

Khiron Reports Q2 Results, 47% QoQ Increase in Medical Cannabis Revenues Driven by Colombia and Germany

PR Newswire August 23, 2021

Khiron to Host Second Quarter 2021 Conference Call on August 23, 2021

PR Newswire August 17, 2021

Khiron Life Sciences Corp.: Invitation to the Q3 Virtual Investor Summit

Newsfile August 11, 2021

Khiron Publishes Inaugural 2020 ESG Report, Demonstrating Commitment to Sustainability and Continued Market Leadership

PR Newswire August 10, 2021

Khiron Welcomes Dr. Eduardo Faveret as Medical Director for Brazil

PR Newswire July 29, 2021

Colombia Expands Distribution of Medical Cannabis to Pharmacies Nationwide and Opens Export Market for Dried Flower Medical Cannabis

PR Newswire July 26, 2021

Khiron Life Sciences Closes $12.3 Million Equity Financing

PR Newswire July 8, 2021

Khiron Life Sciences Announces Terms of Overnight Marketed Offering

PR Newswire July 6, 2021

Khiron Life Sciences Announces Proposed Offering of Securities

PR Newswire July 5, 2021

Khiron Announces Results of 2021 Annual General Meeting

PR Newswire July 2, 2021